Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis.
The purpose of this study was to examine the relationship between patient management strategies employed by study personnel, and patient retention and adherence to treatment in the first year of a Phase III clinical trial of interferon beta-1b for treatment of secondary progressive multiple sclerosis (MS). Study staff from each of 35 sites were interviewed regarding patient management practices. Sites which were rated as more empathetic, as instilling a sense of purpose in the patient, and promoting less formal relationships with patients had high rates of adherence to treatment. In addressing specific patient concerns, attention to patients' emotional status and patients' expectations of trial participation were related to better adherence.
UCSF/Mt. Zion MS Center, San Francisco, CA 94115-1642, USA.
D C
DC
Mohr
D E
DE
Goodkin
L
L
Masuoka
L P
LP
Dick
D
D
Russo
J
J
Eckhardt
A C
AC
Boudewyn
L
L
Bedell
D003627:Data Interpretation, Statistical; D004644:Emotions; D006801:Humans; D016899:Interferon-beta / Q000009:adverse effects / Q000627:therapeutic use*; D007407:Interviews as Topic; D009103:Multiple Sclerosis / Q000523:psychology / Q000628:therapy*; D010349:Patient Compliance; D010353:Patient Education as Topic; D016896:Treatment Outcome
D016899:Interferon-beta